Short progression‐free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2003-11, Vol.123 (4), p.746-747
Hauptverfasser:	Musto, Pellegrino, Carella, Angelo Michele, Greco, Michele Mario, Falcone, Antonietta, Sanpaolo, Grazia, Bodenizza, Carlo, Cascavilla, Nicola, Melillo, Lorella
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols - therapeutic use anti‐CD20 autologous stem cell transplantation Combined Modality Therapy Disease-Free Survival Female Hematology Humans Male Middle Aged multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - mortality Multiple Myeloma - therapy Peripheral Blood Stem Cell Transplantation Rituximab Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!